Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
A Phase I/Randomized Phase II Study of MLN0128 (TAK-228) vs. Pazopanib in Patients With Locally Advanced/Unresectable and/or Metastatic Sarcoma
Status: Enrolling
Updated:  12/31/1969
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
A Phase I/Randomized Phase II Study of MLN0128 (TAK-228) vs. Pazopanib in Patients With Locally Advanced/Unresectable and/or Metastatic Sarcoma
Status: Enrolling
Updated: 12/31/1969
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Compass Research LLC
mi
from
Orlando, FL
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Rowe Neurology Institute
mi
from
Lenexa, KA
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Rowe Neurology Institute
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Parexel International
mi
from
Baltimore, MD
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Parexel International
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
MIND
mi
from
Farmington Hills, MI
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
MIND
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Tri-State Mountain Neurology
mi
from
Johnson City, TN
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Tri-State Mountain Neurology
mi
from
Johnson City, TN
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Network
mi
from
Houston, TX
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Integrated Neurology Services
mi
from
Alexandria, VA
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Integrated Neurology Services
mi
from
Alexandria, VA
Click here to add this to my saved trials
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
Status: Enrolling
Updated:  12/31/1969
Sharp Mary Birch Hospital for Women and Newborns
mi
from
San Diego, CA
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
Status: Enrolling
Updated: 12/31/1969
Sharp Mary Birch Hospital for Women and Newborns
mi
from
San Diego, CA
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of California San Francisco Benioff Children's Hospital
mi
from
San Francisco, CA
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis School of Medicine
mi
from
Saint Louis, MO
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Shriners Hospital for Children-Portland
mi
from
Portland, OR
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Shriners Hospital for Children-Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center Ambulatory Care Pavilion
mi
from
Dallas, TX
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center Ambulatory Care Pavilion
mi
from
Dallas, TX
Click here to add this to my saved trials
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Rare Disease Research, LLC
mi
from
Atlanta, GA
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Rare Disease Research, LLC
mi
from
Atlanta, GA
Click here to add this to my saved trials
Food Allergy Challenge Diagnostic Study
An Exploratory Pilot Study Evaluating Various Diagnostic Measurements Taken During an Escalating Dose Oral Food Challenge to Patient Response
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Food Allergy Challenge Diagnostic Study
An Exploratory Pilot Study Evaluating Various Diagnostic Measurements Taken During an Escalating Dose Oral Food Challenge to Patient Response
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital Regional Medical Center
mi
from
San Jose, CA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital Regional Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Riverside Radiology and Interventional Associates
mi
from
Columbus, OH
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Riverside Radiology and Interventional Associates
mi
from
Columbus, OH
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
St Vincent Mercy Hospital
mi
from
Toledo, OH
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
St Vincent Mercy Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
OHSU Stroke Center
mi
from
Portland, OR
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
OHSU Stroke Center
mi
from
Portland, OR
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
UPMC Stroke Center
mi
from
Pittsburgh, PA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
UPMC Stroke Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Tennessee Interventional and Imaging Associates
mi
from
Chattanooga, TN
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Tennessee Interventional and Imaging Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
AZ Groeninge
mi
from
Kortrijk,
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
AZ Groeninge
mi
from
Kortrijk,
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy
Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy
Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Robot-Mediated Intervention for Children With Autism Spectrum Disorders
Robot-Mediated Social Skills Intervention for Children With Autism Spectrum Disorders
Status: Enrolling
Updated:  12/31/1969
Kennedy Krieger Institute
mi
from
Baltimore, MD
Robot-Mediated Intervention for Children With Autism Spectrum Disorders
Robot-Mediated Social Skills Intervention for Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 12/31/1969
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
Status: Enrolling
Updated:  12/31/1969
Alberto Espay
mi
from
Cincinnati, OH
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
Status: Enrolling
Updated: 12/31/1969
Alberto Espay
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation for Dementia
Repetitive Transcranial Magnetic Stimulation for Dementia
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Repetitive Transcranial Magnetic Stimulation for Dementia
Repetitive Transcranial Magnetic Stimulation for Dementia
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia
Transcranial Direct Current Stimulation in Acute and Chronic Post-stroke Aphasia
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Medicine
mi
from
Baltimore, MD
Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia
Transcranial Direct Current Stimulation in Acute and Chronic Post-stroke Aphasia
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy
A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy
Status: Enrolling
Updated:  12/31/1969
Orthopedic Institute
mi
from
San Francisco, CA
A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy
A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy
Status: Enrolling
Updated: 12/31/1969
Orthopedic Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Alabama Neurology Associates
mi
from
Homewood, AL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Alabama Neurology Associates
mi
from
Homewood, AL
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Territory Neurology & Research Institute
mi
from
Tucson, AZ
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Territory Neurology & Research Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Colorado Springs Neurological Associates
mi
from
Colorado Springs, CO
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Colorado Springs Neurological Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Advanced Neurosciences Research, LLC
mi
from
Fort Collins, CO
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Advanced Neurosciences Research, LLC
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Associated Neurologists of Southern Connecticut, PC
mi
from
Fairfield, CT
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Associated Neurologists of Southern Connecticut, PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Emery Neuroscience Center
mi
from
Lighthouse Point, FL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Emery Neuroscience Center
mi
from
Lighthouse Point, FL
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Neurology Associates, PA
mi
from
Maitland, FL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Neurology Associates, PA
mi
from
Maitland, FL
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Cordova Research Institute
mi
from
Miami, FL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Cordova Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Collier Neurologic Specialists
mi
from
Naples, FL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Collier Neurologic Specialists
mi
from
Naples, FL
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Florida Neurological Center
mi
from
Ocala, FL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Florida Neurological Center
mi
from
Ocala, FL
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Neurological Services Orlando
mi
from
Orlando, FL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Neurological Services Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated:  12/31/1969
Neurology Associates of Ormond Beach
mi
from
Ormond Beach, FL
Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse
Status: Enrolling
Updated: 12/31/1969
Neurology Associates of Ormond Beach
mi
from
Ormond Beach, FL
Click here to add this to my saved trials